129649-15-6Relevant academic research and scientific papers
ANTIDIABETIC OXAZOLIDINEDIONES AND THIAZOLIDINEDIONES
-
Page/Page column 23, (2008/06/13)
Pyridinyloxyphenyl and pyridinyloxybenzyl oxazolidine-2,4-diones and thiazolidine-2,4-diones are agonists or partial agonists of PPAR gamma and are useful in the treatment and control of hyperglycemia that is symptomatic of type II diabetes, as well as dy
ANTIDIABETIC OXAZOLIDINEDIONES AND THIAZOLIDINEDIONES
-
Page/Page column 31, (2010/11/25)
Phenoxyphenyl and phenoxybenzyl oxazolidine-2,4-diones and thiazolidine-2,4-diones are agonists or partial agonists of PPAR gamma and are useful in the treatment and control of hyperglycemia that is symptomatic of type II diabetes, as well as dyslipidemia
ANTIDIABETIC OXAZOLIDINEDIONES AND THIAZOLIDINEDIONES
-
Page/Page column 27, (2010/02/13)
Phenoxyphenyl and phenoxybenzyl oxazolidine-2,4-diones and thiazolidine-2,4-diones of formula (I) are agonists or partial agonists of PPAR gamma and are useful in the treatment and control of hyperglycemia that is symptomatic of type II diabetes, as well
The development of a novel series of (quinolin-2-ylmethoxy)phenyl-containing compounds as high-affinity leukotriene receptor antagonists. 3. Structural variation of the acidic side chain to give antagonists of enhanced potency
Galemmo Jr.,Johnson Jr.,Learn,Lee,Huang,Campbell,Youssefyeh,O'Rourke,Schuessler,Sweeney,Travis,Sutherland,Nuss,Carnathan,Van Inwegen
, p. 2828 - 2841 (2007/10/02)
This paper is the third in a series outlining the development of orally active sulfido peptide leukotriene antagonists containing a (quinolin-2-ylmethoxy)phenyl moiety. In this work the systematic variation of the acid side chain substituents led to drama
